Prospective evaluation of prognostic factors uPA/PAI-1 in node-negative breast cancer: Phase III NNBC3-Europe trial (AGO, GBG, EORTC-PBG) comparing 6 × FEC versus 3 × FEC/3 × Docetaxel

BACKGROUND: Today, more than 70% of patients with primary node-negative breast cancer are cured by local therapy alone. Many patients receive overtreatment by adjuvant chemotherapy due to inadequate risk assessment. So far, few clinical trials have prospectively evaluated tumor biology based prognos...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Kantelhardt, Eva J, Vetter, Martina, Schmidt, Marcus, Veyret, Corinne, Augustin, Doris, Hanf, Volker, Meisner, Christoph, Paepke, Daniela, Schmitt, Manfred, Sweep, Fred, von Minckwitz, Gunter, Martin, Pierre-Marie, Jaenicke, Fritz, Thomssen, Christoph, Harbeck, Nadia
Médium: Artigo
Jazyk:Inglês
Vydáno: BioMed Central 2011
Témata:
Study Protocol
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3089797/
https://ncbi.nlm.nih.gov/pubmed/21496284
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2407-11-140
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky